United States · FDA National Drug Code directory
VIR Combination
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43742-2539_2413e6df-b75a-43da-859c-7d596587764e
- Product NDC
- 43742-2539
- Form
- LIQUID
- Composition / generic term
- Adenoviren Nosode, Cytomegalovirus Nosode, Herpes Simplex Virus 1 and 2 DNA, Epstein-Barr Virus Nosode, Hepatitis B Nosode, Herpes Simplex I and II Nosode, Human Herpesvirus 6A, Human Herpesvirus 6B, Influenzinum
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start / end (source format)
- 20260326
- Source listing expiry
- 20271231
Source-listed ingredients
- HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN — 12 [hp_C]/mL
- HUMAN HERPESVIRUS 5 — 18 [hp_X]/mL
- HERRING SPERM DNA — 12 [hp_X]/mL
- HUMAN HERPESVIRUS 4 — 16 [hp_C]/mL
- HEPATITIS B VIRUS — 33 [hp_X]/mL
- HUMAN HERPESVIRUS 1 — 15 [hp_X]/mL
- HUMAN HERPESVIRUS 2 — 15 [hp_X]/mL
- HUMAN HERPESVIRUS 6 — 15 [hp_X]/mL
- INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_C]/mL
- INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) — 12 [hp_C]/mL
- INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE — 12 [hp_C]/mL
- INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE — 12 [hp_C]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 BOTTLE, DROPPER (43742-2539-1) · 43742-2539-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →